The epitopes are derived from four TAAs that are either over-expressed (BCAN, BIRC5, PTPRZ1 [Supplementary Fig. 1b]) or where the epitope is over-presented (NLGNX4) in a large proportion of GBM tumours compared with most healthy tissues [28]. Here, BIRC5 is linked to glioblastoma.